Interesting paper on changes in life expectancy in Europe.
With cardiovascular disease identified as a major risk factor it will be interesting to see how the trends change as Semaglutide and other drugs increase in use.
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(25)00009-X/fulltext
With cardiovascular disease identified as a major risk factor it will be interesting to see how the trends change as Semaglutide and other drugs increase in use.
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(25)00009-X/fulltext
Comments
Probably too early to see their effect on national trends in life expectancy.